PL2492266T3 - Pochodna 5-hydroksypirymidyno-4-karboksamidu - Google Patents
Pochodna 5-hydroksypirymidyno-4-karboksamiduInfo
- Publication number
- PL2492266T3 PL2492266T3 PL10824975T PL10824975T PL2492266T3 PL 2492266 T3 PL2492266 T3 PL 2492266T3 PL 10824975 T PL10824975 T PL 10824975T PL 10824975 T PL10824975 T PL 10824975T PL 2492266 T3 PL2492266 T3 PL 2492266T3
- Authority
- PL
- Poland
- Prior art keywords
- hydroxypyrimidine
- carboxamide derivative
- carboxamide
- derivative
- Prior art date
Links
- BEUMBMWUTPTRGO-UHFFFAOYSA-N 5-hydroxypyrimidine-4-carboxamide Chemical class NC(=O)C1=NC=NC=C1O BEUMBMWUTPTRGO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009242884 | 2009-10-21 | ||
| EP10824975.6A EP2492266B1 (en) | 2009-10-21 | 2010-10-20 | 5-hydroxypyrimidine-4-carboxamide derivative |
| PCT/JP2010/068476 WO2011049126A1 (ja) | 2009-10-21 | 2010-10-20 | ５－ヒドロキシピリミジン－４－カルボキサミド誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2492266T3 true PL2492266T3 (pl) | 2016-01-29 |
Family
ID=43900350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10824975T PL2492266T3 (pl) | 2009-10-21 | 2010-10-20 | Pochodna 5-hydroksypirymidyno-4-karboksamidu |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8785462B2 (pl) |
| EP (1) | EP2492266B1 (pl) |
| JP (1) | JP5718236B2 (pl) |
| KR (1) | KR101665749B1 (pl) |
| CN (1) | CN102712619B (pl) |
| AU (1) | AU2010308942C1 (pl) |
| BR (1) | BR112012009452A2 (pl) |
| CA (1) | CA2780533C (pl) |
| CO (1) | CO6460726A2 (pl) |
| CY (1) | CY1116974T1 (pl) |
| DK (1) | DK2492266T3 (pl) |
| ES (1) | ES2549503T3 (pl) |
| HR (1) | HRP20151110T1 (pl) |
| HU (1) | HUE026128T2 (pl) |
| IL (1) | IL219243A (pl) |
| MX (1) | MX2012004714A (pl) |
| MY (1) | MY163022A (pl) |
| NZ (1) | NZ600017A (pl) |
| PH (1) | PH12012500770A1 (pl) |
| PL (1) | PL2492266T3 (pl) |
| PT (1) | PT2492266E (pl) |
| RS (1) | RS54323B1 (pl) |
| RU (1) | RU2550693C2 (pl) |
| SI (1) | SI2492266T1 (pl) |
| SM (1) | SMT201500268B (pl) |
| TW (2) | TWI469975B (pl) |
| WO (2) | WO2011049126A1 (pl) |
| ZA (1) | ZA201202899B (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0734218B2 (ja) | 1987-02-25 | 1995-04-12 | オムロン株式会社 | 紙葉類の放出装置 |
| KR101665749B1 (ko) | 2009-10-21 | 2016-10-12 | 다이이찌 산쿄 가부시키가이샤 | 5-하이드록시피리미딘-4-카르복사미드 유도체 |
| TW201400472A (zh) * | 2012-03-30 | 2014-01-01 | Daiichi Sankyo Co Ltd | ５－羥基嘧啶－４－甲醯胺衍生物 |
| IN2014DN08653A (pl) * | 2012-03-30 | 2015-05-22 | Daiichi Sankyo Companyltd | |
| ES2767583T3 (es) * | 2012-10-26 | 2020-06-18 | Agc Inc | Método para fabricar un compuesto de difluorolactona |
| WO2016054804A1 (en) * | 2014-10-10 | 2016-04-14 | Merck Sharp & Dohme Corp. | Substituted pyrimidines as inhibitors of hif prolyl hydroxylase |
| JPWO2017104725A1 (ja) * | 2015-12-16 | 2018-10-04 | 第一三共株式会社 | 創傷治療剤 |
| EP3441070A4 (en) * | 2016-04-08 | 2019-12-11 | Keio University | MEDICINES FOR PREVENTING OR TREATING LACTATACIDOSIS |
| WO2019099294A1 (en) * | 2017-11-14 | 2019-05-23 | Merck Sharp & Dohme Corp. | Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors |
| TW201936598A (zh) * | 2018-02-19 | 2019-09-16 | 日商第一三共股份有限公司 | 炎症性腸病治療劑 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2298301T3 (en) | 2001-12-06 | 2018-10-01 | Fibrogen Inc | MEDICINALS FOR TREATMENT OF ANEMIA ASSOCIATED WITH Kidney Disease |
| WO2004108681A1 (en) | 2003-06-06 | 2004-12-16 | Fibrogen, Inc. | Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin |
| US7501538B2 (en) | 2003-08-08 | 2009-03-10 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions and methods of use |
| AU2006254897A1 (en) | 2005-06-06 | 2006-12-14 | Fibrogen, Inc. | Improved treatment for anemia using a HIF-alpha stabilising agent |
| WO2007038571A2 (en) | 2005-09-26 | 2007-04-05 | Smithkline Beecham Corporation | Prolyl hydroxylase antagonists |
| US20090176825A1 (en) | 2006-05-16 | 2009-07-09 | Fitch Duke M | Prolyl hydroxylase inhibitors |
| JO2934B1 (en) * | 2006-06-23 | 2015-09-15 | سميث كلاين بيتشام كوربوريشن | Prolyl hydroxylase inhibitors |
| PL3357911T3 (pl) | 2006-06-26 | 2022-09-05 | Akebia Therapeutics Inc. | Inhibitory prolilohydroksylazy i sposoby ich użycia |
| TW200845991A (en) | 2007-01-12 | 2008-12-01 | Smithkline Beecham Corp | N-substituted glycine derivatives: hydroxylase inhibitors |
| TW200845994A (en) * | 2007-01-12 | 2008-12-01 | Smithkline Beecham Corp | N-substituted glycine derivatives: prolyl hydroxylase inhibitors |
| ES2524883T3 (es) | 2008-03-18 | 2014-12-15 | Merck Sharp & Dohme Corp. | 4-Hidroxipirimidina-5-carboxamidas sustituidas |
| WO2009131127A1 (ja) * | 2008-04-22 | 2009-10-29 | 第一三共株式会社 | ５－ヒドロキシピリミジン－４－カルボキサミド化合物 |
| KR101665749B1 (ko) | 2009-10-21 | 2016-10-12 | 다이이찌 산쿄 가부시키가이샤 | 5-하이드록시피리미딘-4-카르복사미드 유도체 |
| JP2011105708A (ja) * | 2009-10-21 | 2011-06-02 | Daiichi Sankyo Co Ltd | ５−ヒドロキシピリミジン−４−カルボキサミド化合物を含有する医薬組成物 |
| TW201141839A (en) | 2010-04-19 | 2011-12-01 | Daiichi Sankyo Co Ltd | Substituted 5-hydroxypyrimidine-4-carboxamide compounds |
-
2010
- 2010-10-20 KR KR1020127010014A patent/KR101665749B1/ko not_active Expired - Fee Related
- 2010-10-20 HU HUE10824975A patent/HUE026128T2/en unknown
- 2010-10-20 ES ES10824975.6T patent/ES2549503T3/es active Active
- 2010-10-20 NZ NZ600017A patent/NZ600017A/en not_active IP Right Cessation
- 2010-10-20 WO PCT/JP2010/068476 patent/WO2011049126A1/ja not_active Ceased
- 2010-10-20 CA CA2780533A patent/CA2780533C/en active Active
- 2010-10-20 CN CN201080058211.0A patent/CN102712619B/zh not_active Expired - Fee Related
- 2010-10-20 PH PH1/2012/500770A patent/PH12012500770A1/en unknown
- 2010-10-20 TW TW99135723A patent/TWI469975B/zh not_active IP Right Cessation
- 2010-10-20 AU AU2010308942A patent/AU2010308942C1/en not_active Ceased
- 2010-10-20 WO PCT/JP2010/068477 patent/WO2011049127A1/ja not_active Ceased
- 2010-10-20 PT PT108249756T patent/PT2492266E/pt unknown
- 2010-10-20 RU RU2012120749/04A patent/RU2550693C2/ru active
- 2010-10-20 US US13/503,340 patent/US8785462B2/en active Active
- 2010-10-20 HR HRP20151110TT patent/HRP20151110T1/hr unknown
- 2010-10-20 SI SI201031047T patent/SI2492266T1/sl unknown
- 2010-10-20 DK DK10824975.6T patent/DK2492266T3/en active
- 2010-10-20 EP EP10824975.6A patent/EP2492266B1/en active Active
- 2010-10-20 RS RS20150670A patent/RS54323B1/sr unknown
- 2010-10-20 TW TW099135716A patent/TW201124397A/zh unknown
- 2010-10-20 BR BR112012009452A patent/BR112012009452A2/pt not_active Application Discontinuation
- 2010-10-20 JP JP2011537279A patent/JP5718236B2/ja not_active Expired - Fee Related
- 2010-10-20 MY MYPI2012001770A patent/MY163022A/en unknown
- 2010-10-20 PL PL10824975T patent/PL2492266T3/pl unknown
- 2010-10-20 MX MX2012004714A patent/MX2012004714A/es active IP Right Grant
-
2012
- 2012-04-17 IL IL219243A patent/IL219243A/en active IP Right Grant
- 2012-04-19 ZA ZA2012/02899A patent/ZA201202899B/en unknown
- 2012-05-18 CO CO12082335A patent/CO6460726A2/es unknown
-
2015
- 2015-10-28 SM SM201500268T patent/SMT201500268B/it unknown
- 2015-11-24 CY CY20151101058T patent/CY1116974T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2420493A4 (en) | HALOALKYLSULFONANILIDE DERIVATIVES | |
| EP2412708A4 (en) | SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE | |
| EP2514747A4 (en) | SUBSTITUTED AMINOTHIAZINE DERIVATIVE | |
| IL220616A0 (en) | Novel 3 - hydroxy - 5 - arylisothiazole derivative | |
| PT2433940E (pt) | Derivado de espiroimidazolona | |
| ZA201203205B (en) | Benzimidazole-imidazole derivatives | |
| IL217956A0 (en) | N1-sulfonyl-5-fluoropyrimidinone derivatives | |
| IL217953A0 (en) | 5-fluoropyrimidinone derivatives | |
| EP2495238A4 (en) | NEW 3-HYDROXY-5-ARYLISOXAZOLE DERIVATIVE | |
| PL2397480T3 (pl) | Pochodna diazepinodionu | |
| IL216007A0 (en) | Isoxazole-pyridine derivatives | |
| IL215109A0 (en) | Isoxazole-pyridazine derivatives | |
| ZA201106855B (en) | Oxasiazole derivatives | |
| IL214941A0 (en) | Isoxazole-pyrazole derivatives | |
| IL217952A0 (en) | N1-acyl-5-fluoropyrimidinone derivatives | |
| ZA201104991B (en) | Deoxyactagardine derivatives | |
| ZA201202899B (en) | 5-hydroxypyrimidine-4-carboxamide derivative | |
| IL216761A0 (en) | Pyrazinooxazepine derivatives | |
| GB0921967D0 (en) | Novel Aryloxyanilide Derivatives | |
| ZA201104279B (en) | Tetrahydronaphthalen-2-ol derivatives | |
| GB0912499D0 (en) | Indopyl-pyridone derivatives |